Carbapenem resistance inAcinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies

Unknown

(2018)   IUBMB LIFE

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections

(2012) Kimberly Ku et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Deciphering the Function of the Outer Membrane Protein OprD Homologue of Acinetobacter baumannii

(2012) Manuella Catel-Ferreira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression of the Resistance-Nodulation-Cell Division Pump AdeIJK in Acinetobacter baumannii Is Regulated by AdeN, a TetR-Type Regulator

(2012) Nicolas Rosenfeld et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Host-microbe interactions that shape the pathogenesis ofAcinetobacter baumanniiinfection

(2012) Brittany L. Mortensen et al.   CELLULAR MICROBIOLOGY

Editorial Commentary: Closing the Loop--A Colistin Clinical Study to Confirm Dosing Recommendations From PK/PD Modeling

(2012) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study

(2012) L. Dalfino et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate against Acinetobacter baumannii Infections

(2012) Leticia V. Bentancor et al.   INFECTION AND IMMUNITY

Identification of Acinetobacter species: Is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques?

(2012) Adela Álvarez-Buylla et al.   INFECTION GENETICS AND EVOLUTION

Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan

(2012) S. Endo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Stress Response and Virulence Functions of the Acinetobacter baumannii NfuA Fe-S Scaffold Protein

(2012) D. L. Zimbler et al.   JOURNAL OF BACTERIOLOGY

Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter baumannii

(2012) L. V. Bentancor et al.   JOURNAL OF BACTERIOLOGY

Phenotypic, Biochemical, and Molecular Techniques for Detection of Metallo- -Lactamase NDM in Acinetobacter baumannii

(2012) R. A. Bonnin et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rapid Detection of Carbapenem Resistance in Acinetobacter baumannii Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

(2012) Marie Kempf et al.   PLoS One

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

(2012) Guanpingshen Luo et al.   PLoS One

The Acinetobacter baumannii entA Gene Located Outside the Acinetobactin Cluster Is Critical for Siderophore Production, Iron Acquisition and Virulence

(2012) William F. Penwell et al.   PLoS One

Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells

(2012) Younes Smani et al.   PLoS One

Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation

(2012) Jeremy A. Iwashkiw et al.   PLoS Pathogens

Tn125-Related Acquisition ofblaNDM-Like Genes in Acinetobacter baumannii

(2011) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dissemination of an NDM-2-Producing Acinetobacter baumannii Clone in an Israeli Rehabilitation Center

(2011) P. Espinal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem Susceptibility Testing Errors Using Three Automated Systems, Disk Diffusion, Etest, and Broth Microdilution and Carbapenem Resistance Genes in Isolates of Acinetobacter baumannii-calcoaceticus Complex

(2011) Ana Elizabeth Markelz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Police Investigation into Multidrug-Resistant Acinetobacter baumannii Outbreak in Japan

(2011) K. Yuji et al.   CLINICAL INFECTIOUS DISEASES

Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS

(2011) P. Espinal et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST expert rules in antimicrobial susceptibility testing

(2011) R. Leclercq et al.   CLINICAL MICROBIOLOGY AND INFECTION

Expert Systems in Clinical Microbiology

(2011) T. Winstanley et al.   CLINICAL MICROBIOLOGY REVIEWS

Identification of a novel Acinetobacter baumannii clone in a US hospital outbreak by multilocus polymerase chain reaction/electrospray-ionization mass spectrometry

(2011) Audrey N. Schuetz et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients

(2011) A. O. Ajao et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Innate Immune Responses to Systemic Acinetobacter baumannii Infection in Mice: Neutrophils, but Not Interleukin-17, Mediate Host Resistance

(2011) Jessica M. Breslow et al.   INFECTION AND IMMUNITY

Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections

(2011) Leticia V. Bentancor et al.   INFECTION AND IMMUNITY

Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae

(2011) R.L. Swayne et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options

(2011) Marie Kempf et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Insights into Acinetobacter baumannii pathogenicity

(2011) Gustavo M. Cerqueira et al.   IUBMB LIFE

Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan

(2011) Masaki Yamamoto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007

(2011) Yvonne Pfeifer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of a commercial microarray to detect carbapenemase-producing Enterobacteriaceae

(2011) N. Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative activity of carbapenem testing: the COMPACT study

(2011) P. Nordmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

NDM-2 carbapenemase in Acinetobacter baumannii from Egypt

(2011) M. Kaase et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structure–function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii

(2011) Manuella Catel-Ferreira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Value of the Modified Hodge Test for Detection of Emerging Carbapenemases in Enterobacteriaceae

(2011) D. Girlich et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States

(2011) Jennifer M. Adams-Haduch et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States

(2011) Hilmar Wisplinghoff et al.   JOURNAL OF INFECTION

Evaluation of an automated system for the detection of carbapenem resistant Acinetobacter baumannii and assessment of metallo-β-lactamase production using two different phenotyping methods

(2011) Askin Derya Aybey et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Development of a High-Throughput Cloning Strategy for Characterization of Acinetobacter baumannii Drug Transporter Proteins

(2011) Bart A. Eijkelkamp et al.   JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY

Metallo-β-lactamases: a last frontier for β-lactams?

(2011) Giuseppe Cornaglia et al.   LANCET INFECTIOUS DISEASES

Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap)

(2011) Yaser Fattahian et al.   MICROBIAL PATHOGENESIS

Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU)

(2011) Alexandr Nemec et al.   RESEARCH IN MICROBIOLOGY

Optimization of mass spectral features in MALDI-TOF MS profiling of Acinetobacter species

(2011) Ondrej Šedo et al.   SYSTEMATIC AND APPLIED MICROBIOLOGY

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii

(2011) Michael J. McConnell et al.   VACCINE

Are we closing in on an "elusive enemy"? The current status of our battle withAcinetobacter baumannii

(2011) Federico Perez et al.   Virulence

Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients

(2010) M. N. Samtani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii

(2010) S. Coyne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.

(2010) Sébastien Coyne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia

(2010) Y.-C. Chuang et al.   CLINICAL INFECTIOUS DISEASES

Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme

(2010) A. Di Popolo et al.   CLINICAL MICROBIOLOGY AND INFECTION

CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii–calcoaceticus complex

(2010) Kevin S. Akers et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009)

(2010) Rodrigo E. Mendes et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008

(2010) Yun F. (Wayne) Wang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor

(2010) T. A. Russo et al.   INFECTION AND IMMUNITY

Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis

(2010) A. C. Jacobs et al.   INFECTION AND IMMUNITY

Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis

(2010) N. R. Luke et al.   INFECTION AND IMMUNITY

Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan

(2010) Yu-Chi Lin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii

(2010) M. Hornsey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex

(2010) K. S. Akers et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of BD Phoenix, Vitek 2, and MicroScan Automated Systems for Detection and Inference of Mechanisms Responsible for Carbapenem Resistance in Enterobacteriaceae

(2010) N. Woodford et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii

(2010) D. W. Wareham et al.   JOURNAL OF CLINICAL PATHOLOGY

Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii?

(2010) Anna de Breij et al.   PLoS One

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine

(2010) Michael J. McConnell et al.   VACCINE

Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing

(2010) Laura Camarena et al.   PLoS Pathogens

Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections

(2009) G. L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of the VITEK 2 cards for identification and antimicrobial susceptibility testing of non-glucose-fermenting Gram-negative bacilli

(2009) WEN-SHYANG HSIEH et al.   APMIS

Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway

(2009) Canan Kulah et al.   BMC INFECTIOUS DISEASES

Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem

(2009) Scott A. Weisenberg et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Serum resistance ofAcinetobacter baumanniithrough the binding of factor H to outer membrane proteins

(2009) Sang Woo Kim et al.   FEMS MICROBIOLOGY LETTERS

The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells

(2009) J. A. Gaddy et al.   INFECTION AND IMMUNITY

Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model

(2009) P. Koomanachai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

(2009) N. C. Gordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly- -1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation

(2009) A. H. K. Choi et al.   JOURNAL OF BACTERIOLOGY

Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients

(2009) N. C. Gordon et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Penicillin‐Binding Protein 7/8 Contributes to the Survival ofAcinetobacter baumanniiIn Vitro and In Vivo

(2009) Thomas A. Russo et al.   JOURNAL OF INFECTIOUS DISEASES

CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606T to human airway epithelial cells and their inflammatory response

(2009) Anna de Breij et al.   RESEARCH IN MICROBIOLOGY

Whole-Genome Pyrosequencing of an Epidemic Multidrug-Resistant Acinetobacter baumannii Strain Belonging to the European Clone II Group

(2008) M. Iacono et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Correlation of Antimicrobial Resistance with  -Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City

(2008) S. Bratu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells

(2008) Chul Hee Choi et al.   BMC MICROBIOLOGY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital

(2008) Lei Huang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Why are we afraid of Acinetobacter baumannii?

(2008) Federico Perez et al.   Expert Review of Anti-Infective Therapy

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients

(2008) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

(2008) M. S. Oliveira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program

(2008) R. E. Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

(2008) D. E. Karageorgopoulos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model

(2008) P. J. Bergen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Isolation and Characterization of an Autoinducer Synthase from Acinetobacter baumannii

(2008) C. Niu et al.   JOURNAL OF BACTERIOLOGY

Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology

(2008) A. P. Tomaras et al.   MICROBIOLOGY-SGM

Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans

(2008) A. Y. Peleg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Suboptimal Aminoglycoside Dosing in Critically Ill Patients

(2008) Rhonda S Rea et al.   THERAPEUTIC DRUG MONITORING